The University of Southampton
University of Southampton Institutional Repository

Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis

Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis
Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis
Background: Trypsinogen activation peptide (TAP) may be an early marker of severe pancreatitis. Previous studies have included all patients with organ failure in the group with severe pancreatitis, although patients with transient organ failure may have a good prognosis. The aim of this study was to determine the value of urinary TAP estimation for prediction of severity of acute pancreatitis, and to validate use of several markers of prediction of severity against a new, stringent definition of severity.
Methods: Patients with acute pancreatitis were recruited within 24 h of onset of symptoms. Urine and blood samples were collected for 24 h, and Acute Physiology And Chronic Health Evaluation (APACHE) II (24 h), Ranson (48 h) and Glasgow (48 h) scores were calculated. Severe acute pancreatitis was defined by the presence of a local complication or the presence of organ failure for more than 48 h.
Results: Urinary TAP levels were significantly greater in patients with severe pancreatitis than in those with mild disease during the first 36 h of admission. The highest of three estimations of TAP in the first 24 h was as effective as APACHE II at 24 h in predicting severity. At 24 h after admission, urinary TAP was better than C-reactive protein (CRP) in predicting severity. The combination of TAP and CRP at 24 h allowed identification of high- and low-risk groups. The new definition of severity excluded 24 of 190 patients with transient organ failure; none of these patients died.
Conclusion: Use of TAP improved early prediction of the severity of acute pancreatitis. Organ failure that resolves within 48 h does not signify a severe attack of acute pancreatitis.
1027-1033
Johnson, C.D.
e50aa9cd-8c61-4fe3-a0b3-f51cc3a6c74a
Lempinen, M.
63d2c0ac-cc3b-41be-95c3-46d3207ffc3a
Imrie, C.W.
826fae61-a279-410e-bbc4-b41f2e27e385
Puolakkainen, P.
d69e972d-3e7e-412e-acfc-55e5301528a9
Kemppainen, E.
5489bb4d-b1e5-4788-b943-85b2f7cbd2f5
Carter, R.
840a775a-867e-42ba-a7cb-d131c9fdb9c6
McKay, C.
c34ce3ac-e9e2-40ac-a284-e1e1d681082b
Johnson, C.D.
e50aa9cd-8c61-4fe3-a0b3-f51cc3a6c74a
Lempinen, M.
63d2c0ac-cc3b-41be-95c3-46d3207ffc3a
Imrie, C.W.
826fae61-a279-410e-bbc4-b41f2e27e385
Puolakkainen, P.
d69e972d-3e7e-412e-acfc-55e5301528a9
Kemppainen, E.
5489bb4d-b1e5-4788-b943-85b2f7cbd2f5
Carter, R.
840a775a-867e-42ba-a7cb-d131c9fdb9c6
McKay, C.
c34ce3ac-e9e2-40ac-a284-e1e1d681082b

Johnson, C.D., Lempinen, M., Imrie, C.W., Puolakkainen, P., Kemppainen, E., Carter, R. and McKay, C. (2004) Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. British Journal of Surgery, 91 (8), 1027-1033. (doi:10.1002/bjs.4612).

Record type: Article

Abstract

Background: Trypsinogen activation peptide (TAP) may be an early marker of severe pancreatitis. Previous studies have included all patients with organ failure in the group with severe pancreatitis, although patients with transient organ failure may have a good prognosis. The aim of this study was to determine the value of urinary TAP estimation for prediction of severity of acute pancreatitis, and to validate use of several markers of prediction of severity against a new, stringent definition of severity.
Methods: Patients with acute pancreatitis were recruited within 24 h of onset of symptoms. Urine and blood samples were collected for 24 h, and Acute Physiology And Chronic Health Evaluation (APACHE) II (24 h), Ranson (48 h) and Glasgow (48 h) scores were calculated. Severe acute pancreatitis was defined by the presence of a local complication or the presence of organ failure for more than 48 h.
Results: Urinary TAP levels were significantly greater in patients with severe pancreatitis than in those with mild disease during the first 36 h of admission. The highest of three estimations of TAP in the first 24 h was as effective as APACHE II at 24 h in predicting severity. At 24 h after admission, urinary TAP was better than C-reactive protein (CRP) in predicting severity. The combination of TAP and CRP at 24 h allowed identification of high- and low-risk groups. The new definition of severity excluded 24 of 190 patients with transient organ failure; none of these patients died.
Conclusion: Use of TAP improved early prediction of the severity of acute pancreatitis. Organ failure that resolves within 48 h does not signify a severe attack of acute pancreatitis.

This record has no associated files available for download.

More information

Published date: 2004

Identifiers

Local EPrints ID: 26405
URI: http://eprints.soton.ac.uk/id/eprint/26405
PURE UUID: 49326b09-af3a-44c4-9073-a81e7c69a3f7

Catalogue record

Date deposited: 24 Apr 2006
Last modified: 15 Mar 2024 07:10

Export record

Altmetrics

Contributors

Author: C.D. Johnson
Author: M. Lempinen
Author: C.W. Imrie
Author: P. Puolakkainen
Author: E. Kemppainen
Author: R. Carter
Author: C. McKay

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×